Providence Portland Medical Center

Recent papers from Providence Portland Medical Center

1. BRCA1-Associated Protein 1 in SarcomaCancers · 2026
2. Time‐to‐Event Analysis of Clinical Milestones in the ALS Natural History Consortium DatasetMuscle & Nerve · 2026
3. Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trialThe Lancet · 2025
4. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyThe Lancet · 2018
5. Mild Traumatic Brain Injuries in Justice-Involved Individuals and Executive Function Consequences on Transition and Reentry into the CommunityAmerican Journal of Occupational Therapy · 2026
6. Prognostic value of baseline modified barium swallow for perioperative dysphagia in oropharyngeal cancer: Secondary analysis of ECOG-ACRIN E3311Oral Oncology · 2026
7. Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodiesMultiple Sclerosis Journal · 2026
8. Ventral Column Spinal Cord Stimulation for Pain ManagementAmerican Journal of Physical Medicine & Rehabilitation · 2026
9. Ex vivo tumor derived organoid pharmacotyping identifies personalized therapeutic options for biliary tract cancer patientsCancer Research Communications · 2026
10. Sex differences in innate immune cell responses: Impact on cancer immunity and response to therapyFrontiers in Immunology · 2026
11. Inflammasome Activation Limits Radiotherapy-Induced Antitumor Immunity and Shapes CD8+ Responses in a Sex-Dependent Manner 2260523The Journal of Immunology · 2026
12. Fluorescence tracking reveals CD8 T cell recruitment from lymph nodes to irradiated tumors and early activation via type I interferon 2260446The Journal of Immunology · 2026
13. Biofabrication and biomedical manufacturing research frontiers in the United StatesBio-Design and Manufacturing · 2026
14. Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE TrialJournal of Clinical Oncology · 2026
15. Cancer-related microangiopathic hemolytic anemia (CR-MAHA) in a metastatic breast cancer patient with a germ-line ATM single nucleotide variant and an ESR1 fusion variant: insights from a case report on early diagnosis and improved outcomesFrontiers in Oncology · 2026
16. A qualitative exploration of clinicians’ experiences and perceptions of a well-being leadership development training programBMC Health Services Research · 2026
17. Lumpectomy Margins and Local Recurrence in DCISJAMA Surgery · 2026
18. A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcomaJCI Insight · 2026
19. Fluorescence tracking CD8 T cells from tumor-draining lymph nodes to irradiated tumors and their activation in the tumor environmentThe Journal of Immunology · 2026
20. Phase I Dose Escalation and Cohort Expansion of Lorigerlimab, a Bispecific PD-1 × CTLA-4 DART Molecule With Focus on Metastatic Castration-Resistant Prostate CancerJCO oncology advances. · 2026